We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Control Bionics Limited is a medical devices business based in Australia. Control Bionics shares (CBL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Control Bionics has a trailing 12-month revenue of around $3.2 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
| 52-week range | $0.52 - $1.24 |
|---|---|
| 50-day moving average | $0.6235 |
| 200-day moving average | $0.6826 |
| Target price | $3.32 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.55
| 1 month (2021-07-05) | -18.52% |
|---|---|
| 3 months (2021-05-05) | -19.12% |
| Revenue TTM | $3.2 million |
|---|---|
| Gross profit TTM | $2.5 million |
| Return on assets TTM | -11.69% |
| Return on equity TTM | -18.66% |
| Profit margin | -31.4% |
| Book value | 0.559 |
| Market capitalisation | $53.4 million |
TTM: trailing 12 months
We're not expecting Control Bionics to pay a dividend over the next 12 months.
Control Bionics Limited designs, manufactures, and sells wireless wearable electromyography based augmentative and alternative communication technologies that allow users to operate and communicate through a computer using their thoughts and neuroelectric signals. It offers Eye Control Duo, an integrated eye tracking device for those living with paralysis and loss of speech; NeuroNode Trilogy, a solution for those living with paralysis and loss of speech; and Control Bionics Complete Communication System, an out of the box solution for those living with paralysis and loss of speech. The company also provides support and warranty services. The company's products are used by people suffering from diseases, such as motor neuron diseases, amyotrophic lateral sclerosis, cerebral palsy, multiple sclerosis, and spinal cord injuries. It operates in Australia, the United States, Japan, and internationally. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Surrey Hills, Australia.
Everything we know about the WAY2VAT IPO, plus information on how to buy in.
Everything we know about the Pearl Gull Iron IPO, plus information on how to buy in.
Everything we know about the Zoom2u Technologies IPO, plus information on how to buy in.
Copper Search is expected to go public . Here's how to buy in when the IPO launches.
Everything we know about the Alvo Minerals IPO, plus information on how to buy in.
Everything we know about the Star Minerals Limited IPO, plus information on how to buy in.
Everything we know about the Heavy Mineral Limited IPO, plus information on how to buy in.
Everything we know about the X2M Connect IPO, plus information on how to buy in.
Steps to owning and managing Industrial Minerals shares.
Everything we know about the SSH Group IPO, plus information on how to buy in.
